Want to see SE:NNH full AI Analyst Report?
Top Page
New Nordic Healthbrands AB
(NNH)
Select Model
Select Model
Rating:58Neutral
Price Target:
kr17.50
▲(41.70% Upside)
Action:Reiterated
Date:08/04/26
The score reflects a financial recovery with manageable leverage but still-thin and historically volatile profitability/cash flow, which is the biggest constraint. Technicals are supportive due to strong trend momentum above key moving averages, partially offset by overbought readings. Valuation is the main headwind given the high P/E and only modest dividend yield.
Positive Factors
Branded nutraceutical portfolio
A branded portfolio in nutraceuticals and herbal health products can support customer recognition and differentiated positioning across recurring wellness needs. Continued product development and brand investment may help preserve pricing power and sustain access to retail and pharmacy channels over the medium term.
Negative Factors
Thin profitability
Very thin operating and net margins leave limited protection if costs rise, pricing weakens, or product mix becomes less favorable. The narrow earnings buffer makes profits less resilient and means relatively small operational setbacks could materially reduce income over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Branded nutraceutical portfolio
A branded portfolio in nutraceuticals and herbal health products can support customer recognition and differentiated positioning across recurring wellness needs. Continued product development and brand investment may help preserve pricing power and sustain access to retail and pharmacy channels over the medium term.
Read all positive factors
New Nordic Healthbrands AB (NNH) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr109.35M
Dividend Yield1.4%
Average Volume (3M)10.06K
Price to Earnings (P/E)14.1
Beta (1Y)0.43
Revenue Growth3.50%
EPS Growth58.41%
CountrySE
Employees81
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,195,200
10 Day Avg. Volume9,341
30 Day Avg. Volume10,057
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
New Nordic Healthbrands AB Business Overview & Revenue Model
Company Description
New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vit...
How the Company Makes Money
NNH primarily makes money by selling branded health and wellness products (mainly dietary supplements/nutraceuticals) to distribution channels that then sell to end consumers. Revenue is generated through (1) wholesale/B2B sales to retailers, phar...
New Nordic Healthbrands AB Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
66
Positive
Cash Flow
48
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 585.81M | 576.36M | 550.31M | 533.85M | 487.50M | 514.85M |
| Gross Profit | 98.15M | 15.95M | 354.69M | 348.23M | 318.50M | 350.05M |
| EBITDA | 16.58M | 17.61M | -1.43M | -1.94M | -2.57M | 29.34M |
| Net Income | 7.84M | 8.20M | -7.70M | -6.19M | -2.82M | 21.30M |
Balance Sheet | ||||||
| Total Assets | 292.50M | 246.15M | 248.72M | 249.06M | 251.67M | 238.35M |
| Cash, Cash Equivalents and Short-Term Investments | 9.91M | 16.55M | 15.25M | 13.81M | 10.70M | 11.88M |
| Total Debt | 37.06M | 35.84M | 39.22M | 26.64M | 48.35M | 24.43M |
| Total Liabilities | 183.84M | 142.69M | 148.19M | 143.03M | 139.10M | 118.03M |
| Stockholders Equity | 108.65M | 103.47M | 100.92M | 106.03M | 112.57M | 120.32M |
Cash Flow | ||||||
| Free Cash Flow | 5.21M | 7.57M | -6.62M | 25.88M | -18.41M | -10.58M |
| Operating Cash Flow | 5.57M | 8.39M | -5.40M | 28.03M | -15.45M | -7.87M |
| Investing Cash Flow | -3.16M | -3.22M | -3.71M | -3.40M | -2.62M | -2.97M |
| Financing Cash Flow | -2.24M | -3.38M | 10.39M | -21.17M | 16.59M | 12.07M |
New Nordic Healthbrands AB Technical Analysis
Positive
12.35
Price Trends
17.51
Positive
15.30
Positive
16.73
Positive
Market Momentum
0.14
Negative
57.09
Neutral
71.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Positive. The current price of 12.35 is below the 20-day moving average (MA) of 17.44, below the 50-day MA of 17.51, and below the 200-day MA of 16.73, indicating a bullish trend. The MACD of 0.14 indicates Negative momentum. The RSI at 57.09 is Neutral, neither overbought nor oversold. The STOCH value of 71.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NNH.
New Nordic Healthbrands AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | kr5.15B | 11.41 | 48.04% | 4.62% | 32.85% | 101.50% | |
83 Outperform | kr489.22M | 15.43 | ― | 4.40% | 6.76% | 1.88% | |
63 Neutral | kr1.54B | 13.44 | 3.73% | 2.13% | -2.47% | 460.15% | |
58 Neutral | kr109.35M | 14.09 | ― | 1.40% | 3.50% | 58.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | kr12.56M | -0.88 | ― | ― | -21.49% | 69.53% | |
46 Neutral | kr434.50M | -9.60 | ― | ― | 3.26% | 16.82% |
* General Sector Average
SE:NNH
New Nordic Healthbrands AB
17.90
-5.32
-22.91%
SE:ZZ.B
Zinzino AB
130.00
6.80
5.52%
SE:MSON.B
Midsona AB Class B
10.35
2.39
30.04%
SE:ARCTIC
Arctic Blue Beverages AB
0.16
-0.12
-43.53%
SE:ENZY
Enzymatica AB
1.78
-0.36
-16.82%
SE:GENI
Generic Sweden AB
39.80
-6.65
-14.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.